id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0126-0004,FDA,FDA-2004-N-0126,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Fast Track Drug
Development Programs-Designation, Development, and Application Review",Notice,Notice of Approval,2005-10-11T04:00:00Z,2005,10,,,2025-06-05T18:56:42Z,05-20305,0,0,090000648046fcbb
FDA-2004-N-0126-0003,FDA,FDA-2004-N-0126,"Supporting Statement for Fast-Track Drug Devlopment Programs-Designation, Devlopment Programs- Designation, Devlopment, and Application review",Supporting & Related Material,Statement (Supporting and Related Material),2005-10-11T00:00:00Z,2005,10,,,2025-05-09T22:42:07Z,,0,0,090000648046fcba
FDA-2004-N-0126-0002,FDA,FDA-2004-N-0126,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for
Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review",Notice,30 Day Proposed Information Collection,2005-06-07T04:00:00Z,2005,6,2005-06-07T04:00:00Z,2005-07-08T03:59:59Z,2025-06-05T18:54:52Z,05-11206,0,0,090000648046fcb8